初治肿瘤患者心肌纤维化与应变受损的前瞻性病例对照CMR研究
本研究为前瞻性病例对照设计,纳入50例初治弥漫大B细胞淋巴瘤患者与50例年龄性别匹配的健康对照,均在化疗前接受心脏磁共振检查。结果显示肿瘤组native T1显著升高、整体纵向应变显著降低,且native T1是整体纵向应变受损的独立预测因子。提示初治肿瘤患者已存在亚临床心肌改变,心脏磁共振可用于肿瘤心脏病学的早期风险分层。
要点
- 初治淋巴瘤患者心肌native T1升高且整体纵向应变降低,提示化疗前即存在亚临床心肌损伤
- native T1升高可独立预测整体纵向应变受损,可用于早期风险分层
- 左心室质量无显著差异,提示心肌组织学改变可能早于结构性重塑
核心结论
- 初治肿瘤患者存在亚临床心肌改变,表现为native T1升高和整体纵向应变降低
- native T1是整体纵向应变受损的独立预测因子
- 左心室质量无显著差异,提示心肌组织学改变可能早于结构性重塑
- 心脏磁共振是识别早期心肌功能障碍生物标志物的有价值工具
研究设计与样本
- 前瞻性病例对照研究,共纳入100例受试者
- 病例组为50例初治弥漫大B细胞淋巴瘤患者,对照组为50例年龄和性别匹配的健康志愿者
- 所有受试者均在化疗开始前接受全面的心脏磁共振检查
- 采用相关性分析比较两组心肌组织特征与功能参数的差异
关键影像表现/征象
- 初治肿瘤患者心肌native T1值显著高于健康对照
- 初治肿瘤患者整体纵向应变显著降低
- 左心室质量在两组间无显著差异
诊断标准与关键数值
- 肿瘤组native T1值为1007±29毫秒,对照组为976±29毫秒,p<0.001
- 肿瘤组整体纵向应变为-14±2%,对照组为-22±6%,p<0.001
- native T1与整体纵向应变受损的相关性系数R=-0.3,p<0.05
临床应用与阅片要点
- 对初治淋巴瘤患者行心脏磁共振检查时,应关注native T1值和整体纵向应变作为亚临床心肌损伤指标
- 肿瘤患者native T1升高伴整体纵向应变降低提示化疗前已存在心肌组织学与功能异常
- 左心室质量无变化时不能排除心肌早期损伤,需结合组织学参数综合评估
- 心脏磁共振参数可辅助肿瘤心脏病学的风险分层和主动管理决策
局限性
- 研究仅纳入弥漫大B细胞淋巴瘤单一瘤种,结论推广至其他肿瘤需谨慎
- 单中心前瞻性设计,样本量为100例
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Functional and myocardial tissue modifications can occur in treatment-naïve cancer patients, driven by uncontrolled inflammation and neuro-hormonal activation. These mechanisms may result in myocardial alterations that serve as subclinical imaging markers of potential cardiac dysfunction. This study aims to evaluate the role of cardiac magnetic resonance in investigating cancer-associated immune activation and identifying early biomarkers of myocardial damage in treatment-naive cancer patients.
METHODS: This prospective study enrolled 100 participants, including 50 treatment-naive cancer patients affected by diffuse large B cell lymphoma and 50 age- and gender-matched healthy controls. All participants underwent comprehensive cardiac magnetic resonance imaging before starting chemotherapy. Correlation analysis was conducted to identify differences in myocardial tissue characterization and functional parameter between the two groups.
RESULTS: Native T1 values were significantly higher in the cancer cohort compared to controls (1007 ± 29 ms vs. 976 ± 29 ms; p < 0.001), while global longitudinal strain was significantly reduced (- 14 ± 2% vs. - 22 ± 6%; p < 0.001). Correlation analysis identified native T1 as an independent predictor of global longitudinal strain impairment (R = - 0.3; p < 0.05). No significant differences in left ventricular mass were observed, suggesting that myocardial tissue changes may precede structural remodeling.
CONCLUSION: Treatment-naive cancer patients exhibit subclinical myocardial alterations, characterized by elevated native T1 and reduced global longitudinal strain. Cardiac magnetic resonance emerges as a valuable tool for identifying early biomarkers of myocardial dysfunction, offering opportunities for risk stratification and proactive management in cardio-oncology.
引用
- Catapano, Lisi, Stefanini, et al. Myocardial fibrosis and strain impairment in treatment-naïve cancer patients: insights into cancer-related myocardial remodeling from a prospective case-control CMR study. Radiol Med. 2026. PMID: 41563685. doi:10.1007/s11547-026-02178-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。